Of these t(11;14) is known to be of clinical importance in MM and other hematological diseases where it predicts sensibility to the bcl-2 inhibitor, venetoclax [37], while t(4;14) and t(14;16) are known to predict high-risk disease in MM [38]. The gene discussed is BCL2; the disease is Miyoshi myopathy.